Theralase Technologies Inc.Theralase Technologies Inc.Theralase Technologies Inc.

Theralase Technologies Inc.

No trades
See on Supercharts

TLTFF fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Theralase Technologies, Inc. engages in the design, development, and manufacture of patented laser technology platforms used in bio-stimulative and bio-destructive clinical applications in patients. It operates through the Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT) segments. The ACT segment covers the research and development of photo dynamic compounds (PDCs) for the treatment of cancer. The CLT segment is responsible for the company’s medical laser business, which researches, develops, manufactures, and distributes CLT systems to healthcare practitioners predominantly for the healing of pain. The company was founded by Roger J. Dumoulin-White on August 22, 1989 and is headquartered in Toronto, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

TLTFF does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company